Systematic review on the management of irritable bowel syndrome in the European Union.
D000928:Antidepressive Agents / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D005062:European Union / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006296:Health Services / Q000706:statistics & numerical data*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic; D019233:Retreatment; D016896:Treatment Outcome
D000928:Antidepressive Agents; D000930:Antidiarrheals; D005765:Gastrointestinal Agents; D010276:Parasympatholytics